Stay updated on Avadomide and Nivolumab Combo in Adv Melanoma Clinical Trial
Sign up to get notified when there's something new on the Avadomide and Nivolumab Combo in Adv Melanoma Clinical Trial page.

Latest updates to the Avadomide and Nivolumab Combo in Adv Melanoma Clinical Trial page
- Check2 days agoNo Change Detected
- Check10 days agoChange DetectedAdded new MedlinePlus Genetics topic: Melanoma. No deletions.SummaryDifference0.2%
- Check17 days agoChange Detected- Added a government operating-status notice and links, clarifying NIH Clinical Center operations and where to check updates. - Updated version from v3.1.0 to v3.2.0.SummaryDifference4%
- Check24 days agoChange DetectedUpdated the page from revision v3.0.2 to v3.1.0, indicating a version upgrade with no other content changes.SummaryDifference0.1%
- Check31 days agoChange Detected- Removed MedlinePlus Genetics topic: Melanoma. This reduces the genetics-focused content available on the page, potentially narrowing user access to melanoma-related genetic information.SummaryDifference0.2%
- Check39 days agoChange DetectedAdded Melanoma topic under MedlinePlus Genetics and updated to v3.0.2; removed 'Back to Top' navigation.SummaryDifference0.5%
- Check46 days agoChange DetectedThe page has been updated to version 3.0.1, and the topic of Melanoma related to MedlinePlus Genetics has been removed.SummaryDifference0.5%
Stay in the know with updates to Avadomide and Nivolumab Combo in Adv Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avadomide and Nivolumab Combo in Adv Melanoma Clinical Trial page.